Study Preregistration: Testing a Digital Suicide Risk Reduction Platform for Adolescents: A Pragmatic Randomized Controlled Trial - 26/07/24
Doi : 10.1016/j.jaac.2024.03.012
Carter J. Funkhouser, PhD a, b, Trinity C. Tse, BA a, b, Lauren S. Weiner, PhD c, Danielle deLuise, BA c, David Pagliaccio, PhD a, b, Katherine Durham, PhD a, b, Colleen C. Cullen, PsyD a, Zachary K. Blumkin, PsyD a, Casey T. O’Brien, PhD a, Nicholas B. Allen, PhD c, d, Randy P. Auerbach, PhD, ABPP a, b, ⁎ 
a Columbia University, New York
b New York State Psychiatric Institute, New York
c Ksana Health, Inc, Eugene, Oregon
d University of Oregon, Eugene, Oregon
∗Correspondence to Randy P. Auerbach, PhD, ABPP, 1051 Riverside Drive, Pardes 2407, New York, NY 100321051 Riverside DrivePardes 2407New YorkNY10032
Résumé |
Suicide is the second leading cause of death among adolescents, and rates of suicidal thoughts and behaviors (STBs) are climbing.1 Promising interventions such as dialectical behavior therapy (DBT) are available to treat suicidal youth, and new approaches may facilitate greater intervention engagement, adherence, and effectiveness.2 Digital tools (eg, personal smartphones) are a particularly promising avenue and could enhance existing, evidence-based interventions by providing new opportunities for assessment and intervention between sessions.
Le texte complet de cet article est disponible en PDF.Plan
| This study is supported by National Institute of Mental Health grants R44 MH128484 (NBA, RPA), U01 MH116923 (NBA, RPA), R01 MH119771 (RPA), R21 MH125044 (DP), and T32 MH016434 (CJF). The Morgan Stanley Foundation and Tommy Fuss Fund also supported this research project (RPA, DP). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health or any other funding source. |
|
| Consent has been provided for descriptions of specific patient information. |
|
| Drs. Funkhouser and Auerbach served as the statistical experts for this research. |
|
| Disclosure: Drs. Weiner and Allen and Ms. deLuise are employed by, and hold equity in, Ksana Health, which developed and commercialized the Vira platform. Dr. Auerbach has reported being an unpaid scientific advisor for Ksana Health and paid scientific advisor for Get Sonar, Inc. Drs. Funkhouser, Pagliaccio, Durham, Cullen, Blumkin, and O’Brien and Ms. Tse have reported no biomedical financial interests or potential conflicts of interest. |
© 2024
American Academy of Child and Adolescent Psychiatry. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 63 - N° 8
P. 845-847 - août 2024 Retour au numéro
Article précédent
- Mitochondrial DNA Haplogroup K Is Protective Against Autism Spectrum Disorder Risk in Populations of European Ancestry
- Xiao Chang, Hui-Qi Qu, Yichuan Liu, Joseph T. Glessner, Hakon Hakonarson
- Lessons Learned From Magna-Tiles
- Misty C. Richards, Justin Schreiber
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?